BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 1
  • This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (9606)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-5) series.
Item 
Count 
PDF613
WORD278
HTML4656
Figures (1-4)1347
Tables (1-5)546
 Sum=7440
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse863
Download1303
 Sum=2166
Feb 4, 2018 (publication date) through Oct 25, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Critical Care Medicine
ISSN
2220-3141
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews
Copyright ©The Author(s) 2018.
World J Crit Care Med. Feb 4, 2018; 7(1): 24-30
Published online Feb 4, 2018. doi: 10.5492/wjccm.v7.i1.24
Table 1 Characteristics of the sample
Sample characteristics (n = 120)Results
Age (yr)
Mean ± SD58.5 ± 19.4
Minimum-maximum15-91
Gender n (%)
Male69 (57.5)
Female51 (42.5)
APACHE II (score)
Mean ± SD27.4 ± 6.7
Minimum–maximum8-47
Risk of mortality (%)-APACHE II
Mean ± SD61.8 ± 7.3
Admission diagnoses n (%)
Diseases of the circulatory system43 (35.8)
Diseases of the respiratory system15 (12.5)
Lesions, poisoning and other consequences of external causes14 (11.7)
Gastrointestinal diseases8 (6.7)
Unclassified signs and symptoms8 (6.7)
Diseases of the genitourinary system7 (5.8)
Neoplasia4 (3.3)
Nervous system disorders4 (3.3)
Infectious and parasitic diseases3 (2.5)
Endocrine, nutritional and metabolic diseases3 (2.5)
Other11 (9.2)
Mechanical ventilators n (%)
1Servo S89 (74.2)
1Servo 900203 (16.7)
1Dixtal11 (9.2)
1Source: Prepared by the author, 2013.
Full Size Table
Table 2 Respiratory mechanics and oxygenation index on the 1st and 5th day
Oxygenation index
Mean ± SDMinimum-maximum
Respiratory mechanics
1st day (n = 120)
PaO2/FiO2 (mmHg)236.0 ± 97.647.0-465.7
Compliance-VCV (mL/cm H2O)40.9 ± 12.815.0-88.0
Resistance-VCV (cm H2O/L/s)13.2 ± 4.94.1-28.6
Compliance-PCV (mL/cm H2O)35.0 ± 10.015.0-62.0
Resistance-PCV (cm H2O/L/s)27.3 ± 16.29.1-131.1
5th day (n = 77)
PaO2/FiO2 (mmHg)241.7 ± 88.758.0-445.0
Compliance-VCV (mL/cm H2O)39.7 ± 13.218.0-83.0
Resistance-VCV (cm H2O/L/s)13.8 ± 6.05.3-43.0
Compliance-PCV (mL/cm H2O)32.9 ± 9.313.5-52.5
Resistance-PCV (cm H2O/L/s)26.4 ± 11.86.2-73.5
Source: Prepared by the author, 2013. VCV: Volume-controlled ventilation; PCV: Pressure-controlled ventilation.
Full Size Table
Table 3 Numeric variables and ventilator-associated pneumonia
VariablesVAP
P value
YesNo
APACHE II129.2 ± 5.626.5 ± 7.10.026
Age (yr)57.1 ± 19.159.2 ± 19.60.565
1st day (n = 120)
PaO2/FiO2 (mmHg)1232.3 ± 79.9237.8 ± 105.20.756
Compliance-VCV (mL/cmH2O)43.1 ± 14.939.8 ± 11.60.365
Resistance-VCV (cmH2O/L/s)13.7 ± 5.013.0 ± 4.80.594
Compliance-PCV (mL/cmH2O)134.8 ± 10.435.1 ± 9.80.879
Resistance-PCV (cmH2O/L/s)23.6 ± 10.329.0 ± 18.10.114
5th day (n = 77)
PaO2/FiO2 (mmHg)1244.1 ± 94.1240.2 ± 86.10.850
Compliance-VCV (mL/cmH2O)43.3 ± 14.037.6 ± 12.30.092
Resistance-VCV (cmH2O/L/s)13.9 ± 6.813.8 ± 5.50.996
Compliance-PCV (mL/cmH2O)133.6 ± 8.932.5 ± 9.60.606
Resistance-PCV (cmH2O/L/s)27.1 ± 11.725.9 ± 12.00.777
(n = 120)
Duration of MV (d)18.4 ± 14.910.7 ± 6.80.001
Length of stay in ICU (d)20.4 ± 15.312.8 ± 7.60.003
Mann-Whitney U-test;
1Student’s t-test. Source: Prepared by the author, 2013. VAP: Ventilator-associated pneumonia; VCV: Volume-controlled ventilation; PCV: Pressure-controlled ventilation; MV: Mechanical ventilation; ICU: Intensive care unit.
Full Size Table
Table 4 Numeric variables and death
VariablesOutcome
P value
HighDeath
APACHE II127.0 ± 7.627.7 ± 5.80.606
Age (yr)51.1 ± 19.965.4 ± 16.1< 0.001
1st day (n = 120)
PaO2/FiO2 (mmHg)1263.1 ± 100.9210.7 ± 87.80.003
Compliance-VCV (mL/cm H2O)43.5 ± 12.538.4 ± 12.60.015
Resistance-VCV (cm H2O/L/s)13.3 ± 4.313.2 ± 5.40.935
Compliance-PCV (mL/cm H2O)136.6 ± 9.833.6 ± 9.90.103
Resistance-PCV (cm H2O/L/s)25.0 ± 10.529.4 ± 20.00.416
5th day (n = 77)
PaO2/FiO2 (mmHg)1268.8 ± 81.9214.7 ± 87.90.004
Compliance-VCV (mL/cm H2O)40.7 ± 12.738.7 ± 13.70.356
Resistance-VCV (cm H2O/L/s)14.2 ± 5.013.5 ± 6.90.22
Compliance-PCV (mL/cm H2O)134.1 ± 9.431.8 ± 9.10.282
Resistance-PCV (cm H2O/L/s)25.7 ± 10.827.1 ± 12.90.76
(n = 120)
Duration of MV (d)14.5 ± 12.411.9 ± 8.60.212
Length of stay in ICU (d)18.3 ± 12.512.4 ± 8.9< 0.001
Mann-Whitney U-test;
1Student’s t-test. Source: Prepared by the author, 2013. VCV: Volume-controlled ventilation; PCV: Pressure-controlled ventilation; MV: Mechanical ventilation; ICU: Intensive care unit.
Full Size Table
Table 5 Relative risk for ventilator-associated pneumonia and outcomes
VariablesRR95%CIP value
VAP
APACHE II above the average1.621.03-2.550.016
Male gender1.561.18-2.080.004
Resistance worsening-PCV1.851.16-2.940.01
Outcome: Death
Age above the average2.081.34-3.230.001
Compliance-VCV below average on 1st day1.491.00-2.210.032
ICU stay below the average2.051.28-3.280.001
Source: Prepared by the author, 2013. VAP: Ventilator-associated pneumonia; VCV: Volume-controlled ventilation; PCV: Pressure-controlled ventilation; ICU: Intensive care unit.
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345